JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Czernin, J.
Right arrow Articles by Schelbert, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Czernin, J.
Right arrow Articles by Schelbert, H. R.

Improvements in Cancer Staging with PET/CT: Literature-Based Evidence as of September 2006

Johannes Czernin, Martin Allen-Auerbach and Heinrich R. Schelbert

Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Clinic/Nuclear Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California


Figure 1
View larger version (57K):
[in this window]
[in a new window]

 
FIGURE 1.  Whole-body 123I (A) and PET/CT (B–E) images obtained in patient who had history of papillary thyroid cancer and who had been treated with surgery and radioiodine therapy. Patient presented with markedly elevated serum thyroglobulin levels. (A) Normal 123I whole-body scan. Green arrows denote physiologic activity in right submandibular region, stomach, and bladder. (B–E) Coronal whole-body PET/CT, axial PET/CT, axial CT, and axial PET images, respectively. PET/CT revealed intensely increased 18F-FDG uptake in left supraclavicular region, corresponding to lymphadenopathy on CT (yellow arrows). Subsequent surgical resection revealed metastasis from papillary carcinoma.

 

Figure 2
View larger version (97K):
[in this window]
[in a new window]

 
FIGURE 2.  Images obtained in patient with lung cancer after left upper lobectomy and chemotherapy. Study was performed for restaging. (A–D) Coronal whole-body PET/CT, axial PET/CT, axial CT, and axial PET images, respectively. Local recurrence in region of previous resection was evident. Unexpected metastases to left lobe of liver (yellow arrows) and to right iliac bone (red arrow) were identified, underscoring importance of whole-body staging of patients with lung cancer.

 

Figure 3
View larger version (56K):
[in this window]
[in a new window]

 
FIGURE 3.  Coronal PET/CT (A) and axial PET/CT (B), CT (C), and PET (D) images acquired in patient with breast cancer. White arrow on coronal image depicts primary tumor, which was infiltrating ductal carcinoma. Yellow arrows denote metastatic lesion in sternum.

 

Figure 4
View larger version (74K):
[in this window]
[in a new window]

 
FIGURE 4.  Coronal PET/CT (A) and axial PET/CT (B), CT (C), and PET (D) images acquired in patient with colorectal cancer. Increased 18F-FDG uptake in left axilla (yellow arrows), corresponding to lymphadenopathy on CT, was subsequently proven to represent metastatic disease.

 

Figure 5
View larger version (65K):
[in this window]
[in a new window]

 
FIGURE 5.  Coronal PET/CT (A) and axial PET/CT (B), CT (C), and PET (D) images acquired in patient with melanoma. Small focus of moderately increased 18F-FDG uptake corresponded to small soft-tissue nodule on CT (yellow arrows). Biopsy confirmed melanoma, and subsequent surgery for solitary metastasis was performed.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.